Lifestyle study for people with suspected pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how lifestyle changes may affect the course of pancreatic cancer and its treatment. It is for people with a suspicious pancreatic mass who are well enough to receive combination chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are willing to sign a consent form
- You have a suspicious mass in the pancreas seen on a CT scan, MRI, or endoscopic ultrasound (EUS)
- You are healthy enough to receive a combination of chemotherapy drugs (called polychemotherapy)
- You are being treated at San Raffaele Hospital in Milan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This study is looking at healthy adults who have no symptoms or risk factors for pancreatic cancer to test a new imaging method that may help find early signs of the disease. If you join, you will have an endoscopic ultrasound (a thin tube with a camera passed to your stomach) to check your pancreas.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This study is collecting information from people who may have pancreatic cancer to see how a new ultrasound imaging technique (called LINFU) works for helping doctors decide whether a biopsy is needed. Participation could provide better imaging to guide your care.
This trial tests a new study drug called FID-022 for people with pancreatic cancer. It is a first-in-human study, meaning it is the first time this drug is being tested in people, and researchers want to see if it is safe and how it works.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.